Kinsella, A R <br/><br/>
Phenotypic resistance to methotrexate and N-phosphonacetyl L-aspartate is induced by treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA).  [electronic resource] 

 -  International journal of cancer  Jul 1988 
 - 87-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/ijc.2910420117  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aspartic Acid--analogs & derivatives<br/>Cell Line--drug effects<br/>Drug Interactions<br/>Drug Resistance<br/>Gene Amplification--drug effects<br/>Methotrexate--pharmacology<br/>Organophosphorus Compounds--pharmacology<br/>Phenotype<br/>Phosphonoacetic Acid--analogs & derivatives<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Tetrahydrofolate Dehydrogenase--genetics